Strides Pharma suspends sale of Ranitidine tab in US

In a regulatory filing, the company said it has received an Information Request from the USFDA to provide test data related to NDMA impurities in ranitidine tablets.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news